-
Is A Successful Rite-Aid Deal Now Key To Walgreens Maintaining Its Growth?
Saturday, April 1, 2017 - 11:12am | 372Read More...Walgreens Boots Alliance Inc (NASDAQ: WBA) merger with Rite Aid Corporation (NYSE: RAD) is seen as a key catalyst for the company to maintain double-digit growth moving forward. A deal that has been in the works for some time is now expected to close by July, according to Barclays. Walgreens is set...
-
Aggressive Cost Reduction Protects Margins For Walgreens
Thursday, July 7, 2016 - 8:47am | 295Read More...The 3QFY16 financial results indicate that Walgreens Boots Alliance Inc (NASDAQ: WBA) has executed well against synergy and cost reduction targets, Barclays’ Eric Percher said in a report. He maintained an Equal Weight rating on the company, while raising the price target from $76 to $79...
-
Barclays Bullish On Cotiviti Shares
Monday, June 20, 2016 - 2:58pm | 223Read More...Barclays analyst Eric Percher issued a new rating on shares of Cotiviti Holdings Inc (NYSE: COTV). The recommendation followed the expiration of the sell-side quiet period which came on the heels of Cotiviti's initial public offering. Percher set an Overweight rating and $22 price target on...
-
IMS Health May Buy AlphaImpactRX: What's It Mean?
Monday, December 28, 2015 - 11:03am | 233Read More...Barclays on Monday issued a report highlighting IMS Health Holdings Inc. (NYSE: IMS) and its potential acquisition of AlphaImpactRX. The report comes amid news of an FTC antitrust clearance notice. In the report, analysts Manav Patnaik and Eric Percher had several questions following news of...
-
Here's What Barclays Thinks About Athenahealth After Its Investor Day
Friday, December 11, 2015 - 9:33am | 326Read More...Shares of athenahealth, Inc (NASDAQ: ATHN) have appreciated 38.29 percent over the past six months, reaching a high of $167.87 on Dec 1. Barclays’ Eric Percher has maintained an Underweight rating on the company, with a price target of $110. While management presented an “ambitious...
-
Barclays Cuts athenahealth To Underweight, Sees Growth Rate As 'Unsustainable'
Tuesday, November 17, 2015 - 9:38am | 310Read More...The share price of athenahealth, Inc (NASDAQ: ATHN) has appreciated 35.71 percent over the past six months, reaching a high of $166.41 on November 10. Barclays’ Eric Percher has downgraded the rating on the company from Equal-Weight to Underweight, while lowering the price target from...
